CBD Market Leader ISOLF Looks to China for Revenue with Ambition
Listed company Isodiol International Inc. (OCTQB: ISOLF) is a market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of consumer products.
Owning a few pharmaceutical laboratories in the U.K. and the U.S., Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, pharmaceutical grade cannabinoids.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytochemical portfolio and will aggressively continue international expansion into America, Asia and Europe.
Targeting the blooming China’s market, Isodiol began its strategic layout in China in 2015 and has already set up its subsidiary TANG FUNG LIMITED in Macau through its BVI subsidiary. The first stage of purchase and merger of China’s distribution and marketing channel has been completed today.
Isodiol will comply with the China’s Company Law and enter the China’s market steadily.
Media Contact
Company Name: Isodiol International Inc.
Contact Person: Jane Leung
Email: Send Email
Country: United States
Website: https://isodiol.com/
